Viewing StudyNCT00020254



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00020254
Status: COMPLETED
Last Update Posted: 2015-04-29
First Post: 2001-07-11

Brief Title: Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Keywords:
Name View
recurrent prostate cancer View
adenocarcinoma of the prostate View